Analyse

Fundierte Analysen zu Pharmamärkten, Lieferketten, Technologie und Regulierung

#Korean biotech ×

30. Aug. 2026•1 Min. Lesezeit

Celltrion Beats Q2 Market Expectations, Analysts Raise Target Prices

Celltrion reported Q2 revenue of 1.3 trillion KRW and operating profit of 430 billion KRW, surpassing consensus estimates, prompting analysts to lift target prices.